These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The positivity index of the immunoenzyme reaction (ELISA) for cysticercosis in the cerebrospinal fluid (CSF) and in the serum of epilepsy patients]. Bonametti AM, Basile MA, Vaz AJ, Baldy JL, Takiguti CK. Rev Inst Med Trop Sao Paulo; 1992; 34(5):451-8. PubMed ID: 1342110 [Abstract] [Full Text] [Related]
17. Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for the serodiagnosis of neurocysticercosis. Arruda GC, da Silva AD, Quagliato EM, Maretti MA, Rossi CL. Trop Med Int Health; 2005 Oct; 10(10):1005-12. PubMed ID: 16185235 [Abstract] [Full Text] [Related]
18. Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L, Preux PM. Epilepsia; 2003 Jul; 44(7):950-5. PubMed ID: 12823579 [Abstract] [Full Text] [Related]
19. Evaluation of enzyme linked immunosorbent--assay for the detection of anticysticercus antibodies in cerebrospinal fluid from patients with neurocysticercosis. Malla N, Kaur M, Kaur U, Ganguly NK, Mahajan RC. J Hyg Epidemiol Microbiol Immunol; 1992 Jul; 36(2):181-90. PubMed ID: 1512454 [Abstract] [Full Text] [Related]
20. [Electroencephalograms (EEG) in 250 patients with epilepsy in a cysticercosis endemic area in Burundi]. Diagana M, Nsengiyumva G, Tuillas M, Druet-Cabanac M, Bouteille B, Preux PM, Tapie P. Neurophysiol Clin; 2005 Feb; 35(1):1-10. PubMed ID: 15808962 [Abstract] [Full Text] [Related] Page: [Next] [New Search]